Moffitt logo

Clinical Trials Search

Clinical Trial 22096

Cancer Type: Malignant Hematology
Study Type: Treatment
NCT#:

Phase: Phase I
Principal Investigator: Lancet, Jeffrey

Call 813-745-6100
or 1-800-679-0775 Learn More
Overview

Study Title

A Phase 1 Open-Label, Dose-Escalation, Safety, and Tolerability Study of JSP191 as a Second-line Therapy in Subjects with Lower-Risk Myelodysplastic Syndrome (LR-MDS)

Summary

Objective

Treatments

Therapies

Therapy (NOS)

Medications

JSP191 ()

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.